LZYY(SH:603368) 3 6 Ke·2025-12-20 10:34Core Insights - The article discusses the transformation of supply chain management in the pharmaceutical industry, particularly through the collaboration between Liuyao Group and Huawei Cloud, leveraging AI to optimize complex supply chain operations [4][11][25]. Group 1: Industry Challenges - Liuyao Group faces a complex supply chain with over 10,000 SKUs, multiple warehouses, and stringent compliance and time constraints, which creates a systemic challenge in operations [4][6]. - The pharmaceutical industry is experiencing increased pressure due to the normalization of centralized procurement, stricter cold chain traceability, and comprehensive compliance regulations [6][10]. - The inefficiencies in China's logistics, where logistics costs account for approximately 18% of GDP compared to 8% in the U.S., highlight the need for significant improvements in supply chain efficiency [9][10]. Group 2: AI Integration and Transformation - Liuyao Group has partnered with Huawei Cloud to reconstruct its supply chain decision-making system using AI, focusing on data governance, demand forecasting, and intelligent scheduling [4][11][12]. - The integration of AI technologies, such as data lakes and predictive models, allows for real-time visibility and intelligent decision-making within the supply chain [14][19]. - The AI-driven supply chain system enables Liuyao to optimize complex operations, reducing decision-making time and costs while improving efficiency by 15% to 18% [18][19]. Group 3: Future Trends - By 2027, over 50% of large multinational companies are expected to adopt AI and advanced analytics for supply chain management, indicating a global trend towards intelligent supply chains [8][10]. - In China, over 60% of large enterprises are projected to implement AI and intelligent scheduling systems in key supply chain areas within the next three years, reflecting a structural shift in the industry [10][22]. - The shift from experience-driven to intelligent-driven supply chains is becoming a critical variable in determining operational quality, marking a significant turning point for the pharmaceutical distribution industry [25][26].